Oct 5, 2026 08:14PM
Oct 5, 2026 08:13PM
Oct 5, 2026 04:01PM
Oct 5, 2026 04:01PM
Jun 26, 2026 04:06PM
Apr 16, 2026 04:15PM
Apr 16, 2026 04:15PM Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $463.5 Million
Apr 14, 2026 10:38PM
Apr 14, 2026 10:38PM
Apr 13, 2026 04:47PM
Apr 13, 2026 04:46PM
Feb 19, 2026 04:34PM
Oct 15, 2025 04:15PM
Oct 15, 2025 04:15PM Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $316.2 Million
Oct 13, 2025 09:07PM
Oct 13, 2025 09:07PM
Oct 13, 2025 04:01PM
Oct 13, 2025 04:01PM
Feb 27, 2025 04:23PM
Nov 18, 2024 09:18PM
Nov 18, 2024 04:14PM Spyre Therapeutics (SYRE) Announces Proposed Public Offering of its Common Stock and Pre-Funded Warrants
Nov 18, 2024 04:14PM
Nov 12, 2024 07:30AM
Nov 12, 2024 07:30AM
Sep 20, 2024 04:06PM
Sep 6, 2024 04:07PM

73,851 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All